032940 — Wonik Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Annual income statement for Wonik Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	87,494	94,675	108,089	129,877	138,735
Cost of Revenue
Gross Profit	37,032	42,322	50,654	64,044	68,367
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	4,432	88,600	100,692	116,962	129,491
Operating Profit	83,063	6,075	7,397	12,915	9,244
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	101,812	35,817	43,160	3,348	-6,727
Provision for Income Taxes
Net Income After Taxes	79,347	28,432	38,309	-1,384	21,391
Minority Interest
Net Income Before Extraordinary Items
Net Income	79,391	28,488	38,242	-1,724	21,142
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	79,391	28,488	38,242	-1,724	21,142
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,001	1,621	2,098	-110	1,165
Dividends per Share